课题基金 / 基金详情

FLUCONAZOLE AS CHRONIC SUPPRESSIVE VS EPISODIC THERAPY IN HIV PATIENT

FLUCONAZOLE AS CHRONIC SUPPRESSIVE VS EPISODIC THERAPY IN HIV PATIENT
氟康唑作为 HIV 患者的慢性抑制治疗与间歇性治疗
批准号:
6265302
负责人:
MARGRIT CARLSON
金额:
$0.19万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MARGRIT CARLSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Fluconazole (Diflucan) is a commonly prescribed drug to treat thrush and other yeast infection. The purpose of this study is to determine how effective two different treatment regimens are at preventing recurrent episodes of thrush (fungal infection of the mouth), and at preventing the development of resistant thrush (infection that no longer responds to standard treatment).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF QUADRIVALENT: HIV
FLUCONAZOLE AS CHRONIC SUPPRESSIVE VS EPISODIC THERAPY IN HIV PATIENT
COMPARISON OF THE VIROLOGIC EFFECACY OF NELFINAVIR AND/OR DMP-266 IN COMBINATION
ANTIVIRAL ACTIVITY OF T 20 ADMINISTERED TO HIV 1 POSITIVE ADULTS
海外基金